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Paediatric Cardiology Department, Royal Brompton and Hareﬁeld NHS Foundation Trust, London, United KingdomBackground. When considering early survival rates
after pediatric cardiac surgery it is essential to adjust for
risk linked to case complexity. An important but previ-
ously less well understood component of case mix
complexity is comorbidity.
Methods. The National Congenital Heart Disease
Audit data representing all pediatric cardiac surgery
procedures undertaken in the United Kingdom and
Ireland between 2009 and 2014 was used to develop and
test groupings for comorbidity and additional non–
procedure-based risk factors within a risk adjustment
model for 30-day mortality. A mixture of expert
consensus based opinion and empiric statistical analyses
were used to deﬁne and test the new comorbidity groups.
Results. The study dataset consisted of 21,838 pediatric
cardiac surgical procedure episodes in 18,834 patients
with 539 deaths (raw 30-day mortality rate, 2.5%). In
addition to surgical procedure type, primary cardiac
diagnosis, univentricular status, age, weight, procedureAccepted for publication Dec 2, 2016.
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(http://creativecommons.org/licenses/by/4.0/).type (bypass, nonbypass, or hybrid), and era, the new risk
factor groups of non-Down congenital anomalies,
acquired comorbidities, increased severity of illness
indicators (eg, preoperative mechanical ventilation or
circulatory support) and additional cardiac risk factors
(eg, heart muscle conditions and raised pulmonary arte-
rial pressure) all independently increased the risk of
operative mortality.
Conclusions. In an era of low mortality rates across a
wide range of operations, non–procedure-based risk fac-
tors form a vital element of risk adjustment and their
presence leads to wide variations in the predicted risk of a
given operation.
(Ann Thorac Surg 2017;-:-–-)
 2017 The Authors. Published by Elsevier Inc. on behalf
of The Society of Thoracic Surgeons. This is an open
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(http://creativecommons.org/licenses/by/4.0/).ase mix adjustment for pediatric cardiac surgery in-Ccorporates operative complexity as well as the
severity and type of the heart defect, patient age, size, and
further noncardiac aspects of the patient’s health or
condition referred to as comorbidity [1–3]. The Partial
Risk Adjustment in Surgery 1 (PRAiS1) risk model was
developed and validated in 2011 to 2012, based on 10
years of National Congenital Heart Disease Audit
(NCHDA) data from the United Kingdom [2]. Although
the UK national audit data quality involved was in gen-
eral excellent, the 1 area where data quality was poor was
in respect of comorbidity information. For this reason,
although a provisional categorization scheme wasdeveloped (consisting of 4 main groups: Down syndrome,
congenital conditions other than Down syndrome, ac-
quired comorbidity, and prematurity) [2], it was only
feasible to include a simple single factor indicating the
presence/absence of a non-Down comorbidity within the
PRAiS1 risk model. We note that Down syndrome was
not associated with 30-day mortality and hence was not
included in the PRAiS1 risk model [4]. Given the impor-
tance attributed to comorbidity in determining case mix
complexity by stakeholders, it was hoped that inclusion of
comorbidity within the PRAiS1 risk model would result in
more comprehensive capture of comorbidity information
within the national audit dataset and indeed this did turn
out to be the case: the proportion of patients that had a
documented non-Down comorbidity doubled in the
NCHDA dataset from 15% to 30% between 2010 and 2013
[5]. Figure 1 shows the changing proportion of individual
procedure records where speciﬁc reference was made to
comorbidity (presence or absence) over time in theiety of Thoracic Surgeons.
0003-4975/$36.00
http://dx.doi.org/10.1016/j.athoracsur.2016.12.013
Fig 1. The changing proportion of comorbidity information (any code
in a European Pediatric Cardiac Code [EPCC] comorbidity group)
based on individual procedure records over time in the National
Congenital Heart Disease Audit. Note that there is a speciﬁc EPCC
code for no preprocedural risk factors.
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concerns were expressed by stakeholders about the large
range of severity within the conditions included within
the single comorbidity factor in the PRAiS1 risk model,
and further it was noted that certain comorbid conditions
were poorly deﬁned within the NCHDA dataset and
hence potentially a source of systematic bias or what has
been referred to as gaming.
The aim of this study was to review the potential co-
morbidity conditions captured within recent NCHDA
data and to explore options for better incorporating co-
morbidity within an updated version of the risk model
referred to as the PRAiS2 risk model (described by Rogers
and colleagues) [6], including consideration of how to
address inclusion of conditions that were viewed as open
to variable interpretation.Patients and Methods
Dataset
The NCHDA is a mandatory and comprehensive audit of
all pediatric cardiac surgery procedures undertaken in the
United Kingdom and Ireland, with centers subjected to a
continuous and completely inclusive system of validation
that includes the review of a sample of case notes by
external auditors to ensure coding accuracy [7]. Further
information about the study dataset, which consisted of
21,838 pediatric cardiac surgical procedure episodes un-
dertaken in 18,834 patients between 2009 and 2014, with
539 deaths (raw 30-day mortality rate, 2.5%), is available
Rogers and colleagues [6]. The unit of analysis in the study
was a 30-day episode of surgical management and the
outcome was vital status at 30-days following the ﬁrst
surgery in such an episode. The NCHDA dataset uses the
European Pediatric Cardiac Code (EPCC) system [8] and
each procedure can have several different comorbidity
codes recorded.Expert Panel
A clinical expert panel was convened, which included
2 data managers (T.W., J.S.), 3 pediatric cardiac surgeons
(D.A., D.J.B., and V.T.), 2 cardiologists (R.C.F., K.E.), and 2
pediatric cardiac intensive care specialists (K.L.B., S.T.)
representing a range of large and smaller UK centers. The
clinical expert panel and the analytical team worked
iteratively to improve the scope, relevance, and validity of
the comorbidity information included in the risk adjust-
ment model.
Aims of the Expert Panel
The expert panel held 2 face-to-face meetings over the
course of a year and took part in iterative discussion be-
tween these meetings, with the following aims:
1) To explore options for incorporating comorbidity
within the PRAiS2 risk model—options included a list
of individual conditions, a simple count of conditions,
and modiﬁed groupings of comorbidity conditions
building on the previous categories formed during
the development of the PRAiS1 model [2].
2) To identify and exclude comorbidities represented in
the NCHDA dataset that may be difﬁcult to deﬁne
consistently such as where existing deﬁnitions are not
available and conditions that are very rare within the
context of pediatric cardiac surgery or are otherwise
not clinically relevant.Context in Terms of the Wider Risk Adjustment Model
In addition to comorbidity risk factors, which are the
subject of this report, the PRAiS2 risk model is a logistic
regression model including: surgical procedure type (16
distinct risk groups of individual speciﬁc cardiac pro-
cedures), primary cardiac diagnosis (11 risk groups of
individual primary cardiac conditions), age, weight, uni-
ventricular status, procedure type (bypass or nonbypass),
and an era indicator variable showing whether the pro-
cedure episode happened before or after 2013 [6]. Given
the low raw mortality rate and overall number of deaths
(539) there was a limit to the number of free parameters
that could reasonably be included in the risk model and
therefore the analysts advised the expert panel to limit
the number of free parameters related to comorbidity and
additional nonprocedural risk factors to less than 10.
Analyses
The expert panel qualitatively reviewed the entire list of
1,357 EPCC codes with focus on the 776 nonprocedural
codes grouped as shown in Figure 2. The expert panel
considered relevant literature, in particular recent publi-
cations regarding the Society of Thoracic Surgeons
Congenital Heart Surgery Database (STS-CHSD) and cur-
rent STS Risk Model to explore how comorbidity informa-
tion was used within this risk score [3, 9, 10]. Based on
consensus, a list of comorbid conditions that were consid-
ered to represent potential operative risk and to be clearly
deﬁnable was identiﬁed based on speciﬁc EPCC codes.
Fig 2. How individual conditions within European Pediatric Cardiac Code groups mapped to preoperative factors.
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placed into groups linked by common distinct etiology.
Once preliminary comorbidity groups had been
deﬁned, univariate and multivariate logistic regression
were used to explore the association with mortality of
each of the candidate comorbidity groups in turn and
when incorporating all statistically signiﬁcant factors in
the wider PRAiS2 model (see Rogers and colleagues) [6].
With a view to better understanding ﬁrst the face validity
of proposed comorbidity groupings (the extent to which
the proposed comorbidity groups subjectively encapsu-
lated the concept of comorbidity related to pediatric
cardiac surgery) and second the added value within the
risk adjustment model of individual conditions within
each group, the expert panel considered the frequency
and outcomes, based on 30-day surgical episodes, of
individual conditions and comorbidity groups. This was
augmented by review of frequencies of comorbidity
groups in combination and of comorbidity groups based
on age and univentricular status (both important risk
factors included within the risk adjustment model).
Associations between higher risk comorbidity groups and
age or univentricular status were evaluated based on the
chi-square test. In the ﬁnal stages of the process the
expert panel reviewed examples of risk predictions for
individual patients to explore the face validity of the risk
model in respect of the new comorbidity groupings.Results
Preoperative Patient-Speciﬁc Factor Groups
Based on consensus and in consideration of the grouping
options, relevant EPCC codes, and review of relevantliterature [4, 9, 10] the expert panel suggested 6 comor-
bidity groups. Figure 2 displays the EPCC code cate-
gories, from which the individual EPCC codes comprising
each of the 6 comorbidity groups originate.
1) Down syndrome.
2) Congenital comorbidities excluding Down syndrome
(all genetic syndromes, clinical constellations of features
that constitute a recognized syndrome, and congenital
structural defects of organs other than the heart) [11].
3) Acquired comorbidities, (preoperative comorbidities
acquired as a result of heart disease or its treatments,
such as renal failure or necrotizing enterocolitis) [12].
4) Prematurity (birth at a gestational age of less than 37
weeks).
5) Conditions indicating increased severity of illness in
surgical candidates such as preoperative mechanical
ventilation and preoperative mechanical circulatory
support as feature in the current STSRiskModel [9, 13].
The panel noted evidence that additional or acquired
cardiac speciﬁc conditions, in particular elevated pulmo-
nary vascular resistance and impaired ventricular func-
tion, may place surgical candidates at increased risk
[14–16], and therefore proposed the formation of a further
category.
6) Additional cardiac risk factors, as is shown in
Figure 2, conditions within the diagnostic codes for
acquired and postprocedural abnormalities or disor-
ders category (acquired cardiac conditions) [17] were
predominant in this group. Codes were only put
forward for inclusion where they were considered
to have an unambiguously negative impact in any
surgical candidate whatever the primary cardiac
4 BROWN ET AL Ann Thorac Surg
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pulmonary arterial pressure) [18], and codes were
ruled out where it was considered that clinically the
impact of the condition under consideration might be
variable from one patient to another and might even
be the primary indication for surgery (for example
pulmonary regurgitation) [19] or where a code was
highly speciﬁc to a given primary diagnosis that was
already a factor in the risk model (eg, intramural
coronary in transposition of the great arteries) [20].
The wider risk model includes the risk factors of
primary diagnosis and univentricular status, hence the
expert panel elected not to consider prior cardiac surgery
as a preoperative factor given its overlap with these
features.
The expert panel considered that a simple count of
comorbidities could lead to inﬂated predicted risk if
several comorbidity codes for similar conditions were
used, when the actual additional risk from the extra codes
would be minimal. For this reason it was decided not to
include an overall count of comorbidities, or a count
within different categories. A yes or no indicator for each
different category of additional risk meant that predicted
risk would be increased if a surgical procedure episode
contained different types of comorbidities or additional
risk factors, while meaning records with several similar
additional risk factors from the same group did not have
any additional weighting for predicted risk.
Statistical Analyses
The frequency with which the preoperative factors were
found within the study dataset are shown in Table 1
alongside the mortality rate for surgical episodes with the
stated factor, whether other preoperative factors were
also present within individual surgical episodes. The
unadjusted odds ratios indicate that the univariate risk of
postoperative death was signiﬁcantly higher for congen-
ital comorbidity, acquired comorbidity, severity of illness
indicator, additional cardiac risk factors, and prematurity.
Conversely, univariate risk of postoperative death was
signﬁcantly lower in surgical episodes with Down syn-
drome. When multivariate risk of postoperative mortality
was considered, there was no longer evidence for
increased risk of postoperative death with prematurity,Table 1. Preoperative Patient Speciﬁc Factors and Outcome
Risk Factor
Number of Episodes
With Risk Factor (%)
Mortality Wit
Risk Factor (%
Acquired comorbidity 1,254 (5.7) 6.5
Additional cardiac risk factors 1,053 (4.8) 5.3
Congenital comorbidity 2,445 (11.2) 3.7
Down syndromea 1,690 (7.7) 1.5
Prematuritya 2,664 (12.2) 4.0
Severity of illness indicator 2,260 (10.3) 7.5
a Prematurity and Down syndrome were not signiﬁcant on multivariate logistic
in Surgery 2 (PRAiS2) risk model, but were included in the adjusted odds rati
CI ¼ conﬁdence interval.most likely because weight and age, which are included
in the PRAiS2 risk adjustment model, were more
important and no longer evidence of signiﬁcantly
reduced risk of death with Down syndrome, most likely
because Down tends to be associated with certain, low-
risk diagnoses and procedures already included in the
PRAiS2 model. The other 4 factors (comorbidity groups)
remained individually statistically signiﬁcant.
Risk Factor Combinations
There were 16,093 (73.7%) surgical episodes with no
additional risk factors in terms of comorbidity and only 10
surgical episodes (<0.1%) with all 4 comorbidity risk
factors present. The most common risk factor as a single
condition was congenital comorbidity in 1,881 (8.6%),
then severity of illness indicator in 1,538 (7.0%), then
additional cardiac risk factors in 656 (3%), and last ac-
quired comorbidity in 575 (2.6%). The most common
combination of 2 risk factor groups was acquired co-
morbidity and severity of illness indicator in 274 (1.3%)
which most likely reﬂects the clinical evolution of end
organ dysfunction (conditions such as necrotizing
enterocolitis or renal failure) in preoperative candidates
that are more unstable and thus requiring preoperative
intensive care supports (Table 2).
Distribution of Risk Factor Variables Within the
Study Population
Based on the chi-square test, the only comorbidity risk
factor that was evenly distributed between age groups
and between functionally univentricular and biven-
tricular hearts was acquired comorbidity. The other 3 risk
factors all had statistically signiﬁcant differences of pro-
portion by age group and by number of functional ven-
tricles (p < 0.01 for all differences, as follows). There was
an increased proportion of surgical episodes with a
severity of illness risk factor in the ﬁrst year of life (when
emergency procedures are more common) as compared
to older children. Congenital comorbidity was more
commonly noted with increasing age at surgical episode,
most likely because certain conditions may take time for
identiﬁcation, and was more common in surgical epi-
sodes for biventricular hearts as compared with func-
tionally univentricular hearts, reﬂecting the distributionh
)
Mortality Without
Risk Factor (%)
Unadjusted Odds
Ratio (95% CI)
Adjusted Odds Ratio
(95% CI) (PRAiS2a)
2.2 3.03 (2.38–3.87) 1.99 (1.52–2.61)
2.3 2.36 (1.78–3.14) 2.20 (1.61–3.03)
2.3 1.61 (1.28–2.03) 1.52 (1.18–1.95)
2.6 0.60 (0.40–0.89) 1.17 (0.72–1.91)
2.3 1.82 (1.46–2.25) 0.87 (0.62–1.20)
1.9 4.23 (3.51–5.11) 1.75 (1.40–2.18)
regression, and hence are not included in the ﬁnal Partial Risk Adjustment
os for this table.
Table 2. Combinations of Comorbidities and Additional Risk Factors
No Additional Cardiac Risk Additional Cardiac Risk Present
No Congenital
Comorbidity
Congenital
Comorbidity
Present
No Congenital
Comorbidity
Congenital
Comorbidity
Present
No acquired comorbidity No severity of illness indicator 16,093 (73.7) 1,881 (8.6) 656 (3.0) 91 (0.4)
Severity of illness indicator Present 1,538 (7.0) 161 (0.7) 143 (0.7) 21 (0.1)
Acquired comorbidity present No severity of illness indicator 575 (2.6) 213 (1.0) 51 (0.2) 18 (0.1)
Severity of illness indicator Present 274 (1.3) 50 (0.2) 63 (0.3) 10 (0.0)
Values are n (%).
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congenital comorbidity (eg, 22q11 deletion). There was a
signiﬁcantly lower proportion in the dataset with addi-
tional cardiac risk factors undergoing surgery in child-
hood than in infancy and with functionally univentricular
as compared to biventricular circulation. This aspect re-
quires further research into long term outcomes based on
underlying primary cardiac diagnosis since it may reﬂect
an adverse effect of acquired cardiac risk factors on sur-
vival over childhood and with certain more high risk
CHD types (Table 3).Risk Factors and Risk Prediction for Individual Patients
Table 4 displays a series of individual patients A to C, D to
F, and G and H that have similar characteristics in respect
of speciﬁc procedure, weight, age, and primary cardiac
diagnosis. There are differences shown in terms of the
individual additional risk factors (congenital comorbidity,
acquired comorbidity, severity of illness, and additional
cardiac risk factors), and the calculated risk predictions
based on the PRAiS1 and PRAiS2 risk models show how
dramatically predicted risk may change based on the way
that these variables are dealt with in the risk adjustment
model. Patients A, B, and C are all children with hypo-
plastic left heart syndrome that have undergone a Fontan
operation, which is a low-risk procedure. Patient A has an
additional cardiac risk factor and his risk is higher based
on the PRAiS2 model than the PRAiS1 model, because the
PRAiS1 model did not include consideration of additional
cardiac risk factors. Patient B has no additional risk fac-
tors and his risk is almost identical between the PRAiS1Table 3. Preoperative Risk Factors or Comorbidities in Relation to
Risk Factor
Neonatal
Episodes
Infant
Episodes
Congenital comorbidity 387 (8.2) 1,005 (11.6
Acquired comorbidity 298 (6.3) 491 (5.7)
Severity of illness indicator 1,102 (23.4) 996 (23.4
Additional cardiac risk factors 197 (4.2) 590 (4.2)
Total 4,709 8,685
Values are n (%). There were statistically signiﬁcant differences (p < 0.01) in ter
by age and by number of functional ventricles for congenital comorbidities, s
chi-square test.and PRAiS2 models. Patient C has a congenital comor-
bidity and hence within the PRAiS2 model has a speciﬁc
additional risk linked to this risk factor, whereas based on
the PRAiS1 model the additional risk is a broad non–
procedure-based factor risk that incorporates the com-
bined inﬂuence of a range of different comorbidities that
were all grouped together as non-Down comorbidity risk
factor in the PRAiS1 model.Comment
Nonprocedural risk factors are important components of
multivariate risk for 30-day outcome of pediatric cardiac
surgery. The average risk associated with pediatric
cardiac surgery is now very low (in this national dataset
related to pediatric cardiac surgery between 2009 and
2014, the raw 30-day mortality rate was 2.5%), and speciﬁc
procedures may be banded together into groups with
similar (and in the majority of cases, low) risk: the
discrimination of risk within such surgical procedure risk
bands may vary considerably based on additional risk
factors and comorbidities. The 4 broad clinical groups of
congenital comorbidity, acquired comorbidity, severity of
illness indicators, and additional cardiac risk factors as
deﬁned based on selected EPCC codes were each
independently associated with increased risk of 30-day
mortality. Consistent deﬁnition and case ascertainment
for such preprocedural risk factors is of key importance
when utilizing them within a risk adjustment model for
research and for driving quality improvement in the care
of pediatric cardiac surgery patients.Age and Number of Functional Ventricles at Surgical Episode
Childhood
Episodes
Univentricular
Episodes
Biventricular
Episodes
) 1,053 (12.5) 310 (8.3) 2,135 (11.8)
465 (5.5) 214 (5.7) 1,040 (5.7)
) 162 (1.9) 325 (8.7) 1,935 (10.7)
266 (3.2) 126 (3.4) 927 (5.1)
8,444 3,737 18,101
ms of the proportion of surgical episodes with the preoperative risk factor
everity of illness indicators, and additional cardiac risk factors based on
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The use of preoperative factors that go beyond procedure
type, primary cardiac diagnosis, age, and weight has
previously been limited by the availability of accurate
registry-based data, with earlier risk adjustment efforts
focused more narrowly [1]. In 2014 and based on recent
data on 25,476 procedures, the STS-CHSD reported
increased mortality rates associated with individual
speciﬁc preoperative risk factors of mechanical circula-
tory support, renal dysfunction, shock, and mechanical
ventilation [13]. These variables have since been included
in the current empiric risk adjustment model supported
by STS-CHSD for use in research and quality assurance
[3], the variables represent important components of
operative risk and vary widely in frequency across
congenital heart programs [21]. We note that although the
treatment of these additional preprocedural risk factors in
terms of groupings differs between the PRAiS2 model
and the current STS Risk Model, the factors or conditions
included have much in common between the 2 risk
adjustment methods.
Strengths and Weaknesses
One of the strengths of our study is that a consensus-
based approach among clinical experts was deployed
alongside empirical data analyses, with the speciﬁc aim of
informing the creation of non–procedure-based risk
groups. This process incorporated a review of every in-
dividual EPCC code by a multidisciplinary panel that
aimed to achieve consistency and to include clinically
important but also crucially readily deﬁnable conditions.
That said, the project deliverables will inevitably reﬂect
the views of the judging panel involved. A weakness of
our methodology is that it is infeasible to pull out the
relative importance of individual conditions that are
grouped together, for example the magnitude of the risk
linked individually to mechanical circulatory support,
shock, mechanical ventilation, severe acidosis and cardiac
arrest may differ. Although it might be clinically inter-
esting to know this, there are limitations in terms of the
absolute number of episodes with certain conditions
present (problems of small numbers and lack of power),
and furthermore there are limitations in terms of the
degrees of freedom for a risk adjustment model (all
important descriptors need to be included while limiting
the number of parameters to avoid overﬁtting).
Conclusions and Future Directions
Although it is recognized that 30-day mortality has more
limited scope as an outcome measure than it did 10 to 20
years ago, and progress has been made to develop other
outcome metrics such as postprocedural morbidities,
30-day mortality remains the most widely used and
accepted benchmark among stakeholders. The new
PRAiS2 risk model, which includes the 4 nonprocedural
risk factor or comorbidity groups, has been validated in
an independent test dataset, as reported in Rogers and
colleagues [6] and has already being used for center-
speciﬁc risk adjustment of 30-day mortality rates in the
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cardiac surgery outcomes. Future analyses of morbidity
outcomes for pediatric cardiac surgery will certainly need
to take account of case complexity in terms of the non-
procedural risk factors and comorbidities.
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(Project No. 14/19/13). The views and opinions expressed therein
are those of the authors and do not necessarily reﬂect those of the
NIHR HS&DR programme or the Department of Health. K.
Brown and V. Tsang were support by the National Institute for
Health Research Biomedical Research Center at Great Ormond
Street Hospital for Children NHS Foundation Trust and
University College London.
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